Figure 4 | Gene Therapy

Figure 4

From: Development of the hybrid Sleeping Beauty-baculovirus vector for sustained gene expression and cancer therapy

Figure 4

Bac-SB-T2hEA/w conferred antitumor effects in mouse prostate cancer models. (a) Tumor volume. (b) Percent survival. Mouse TRAMP-C1 cells (1 × 106 cells per mouse) were injected subcutaneously into the dorsal side of C57BL/6J mice (n=6 for each group). When the tumor volume reached 70 mm3, PBS, Bac-SB-T2luc/w or Bac-SB-T2hEA/w was injected intratumorally at days 0, 3 and 6. **Indicates the significant difference (P<0.005) between the Bac-SB-T2luc/w and Bac-SB-T2hEA/w groups.

Back to article page